Feifei Xie

441 total citations
19 papers, 265 citations indexed

About

Feifei Xie is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Feifei Xie has authored 19 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Feifei Xie's work include Gastric Cancer Management and Outcomes (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Feifei Xie is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Feifei Xie collaborates with scholars based in China, United States and Philippines. Feifei Xie's co-authors include Lijian Tao, Zhang Li, Shuting Wang, Fengxin Zhu, Yuzhi Pang, Miaomiao Zhou, Jing Nie, Yuexiang Wang, Gaoyun Hu and Zhangzhe Peng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Feifei Xie

18 papers receiving 263 citations

Peers

Feifei Xie
Gaosheng Xu China
Yilin Wu China
Hirofumi Ando Japan
Brian K. Stevens United States
Takahiro Tabata Japan
Keng Ye China
Beatriz Palacios Spain
Dongli Tian China
Chihiro Horimai Japan
Gaosheng Xu China
Feifei Xie
Citations per year, relative to Feifei Xie Feifei Xie (= 1×) peers Gaosheng Xu

Countries citing papers authored by Feifei Xie

Since Specialization
Citations

This map shows the geographic impact of Feifei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Xie more than expected).

Fields of papers citing papers by Feifei Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Xie. The network helps show where Feifei Xie may publish in the future.

Co-authorship network of co-authors of Feifei Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Xie. A scholar is included among the top collaborators of Feifei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Xie. Feifei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Tiantian, Feifei Xie, Ruizhe He, et al.. (2025). Micro-Electro Nanofibrous Dressings Based on PVDF-AgNPs as Wound Healing Materials to Promote Healing in Active Areas. International Journal of Nanomedicine. Volume 20. 771–789. 8 indexed citations
2.
3.
Xie, Feifei, et al.. (2024). Therapeutic efficacy of immunotherapy for gastric cancer metastasis. World Journal of Gastrointestinal Surgery. 16(12). 3881–3886.
4.
5.
Xie, Feifei, Xin Zhen, Xiaomei Chen, et al.. (2022). Dietary choline, via gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α. Frontiers in Physiology. 13. 996166–996166. 8 indexed citations
6.
Xie, Feifei, et al.. (2022). Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis. World Journal of Clinical Cases. 10(5). 1527–1535. 3 indexed citations
7.
Zhang, Lei, Feifei Xie, Xinrong Zhang, et al.. (2021). Gut microbial metabolite TMAO increases peritoneal inflammation and peritonitis risk in peritoneal dialysis patients. Translational research. 240. 50–63. 39 indexed citations
8.
Zhen, Xin, Feifei Xie, Miaomiao Zhou, et al.. (2021). Nicotinamide Supplementation Attenuates Renal Interstitial Fibrosis via Boosting the Activity of Sirtuins. SHILAP Revista de lepidopterología. 7(3). 186–199. 18 indexed citations
9.
Xie, Feifei, Xin Lv, Shuting Wang, et al.. (2020). Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice. The FASEB Journal. 35(1). e21198–e21198. 47 indexed citations
10.
Zhu, Li, Yuzhi Pang, Zhang Li, et al.. (2020). Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors. Gastric Cancer. 23(5). 837–847. 6 indexed citations
11.
Guan, Luyao, Zhang Li, Feifei Xie, et al.. (2020). Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 53–53. 4 indexed citations
12.
Li, Zhang, Chenghao Shao, Xiaoxiao Liu, et al.. (2019). Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Carcinogenesis. 41(1). 44–55. 18 indexed citations
13.
Pang, Yuzhi, Feifei Xie, Hui Cao, et al.. (2019). Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences. 116(45). 22746–22753. 27 indexed citations
14.
Yuan, Xiangning, Jin Zhang, Feifei Xie, et al.. (2017). Loss of the Protein Cystathionine β-Synthase During Kidney Injury Promotes Renal Tubulointerstitial Fibrosis. Kidney & Blood Pressure Research. 42(3). 428–443. 22 indexed citations
15.
Cheng, Haibo, Zhang Li, Yuzhi Pang, et al.. (2017). Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions. Oncotarget. 8(36). 60589–60604. 17 indexed citations
16.
Zhao, Jing, Feifei Xie, Yan Xu, et al.. (2016). A sensitive and practical method to detect the T790M mutation in the epidermal growth factor receptor. Oncology Letters. 11(4). 2573–2579. 15 indexed citations
17.
Zhang, Jin, Linfeng Zheng, Xiangning Yuan, et al.. (2016). Mefunidone ameliorates renal inflammation and tubulointerstitial fibrosis via suppression of IKKβ phosphorylation. The International Journal of Biochemistry & Cell Biology. 80. 109–118. 18 indexed citations
18.
Xie, Feifei, Jie Huang, Shoufang Qu, et al.. (2014). Sensitive detection of trace amounts of KRAS codon 12 mutations by a fast and novel one-step technique. Clinical Biochemistry. 47(16-17). 237–242. 8 indexed citations
19.
Xie, Feifei, Wei Zhong, Weili Wu, et al.. (2012). Restriction endonuclease‐mediated real‐time digestion‐PCR for somatic mutation detection. International Journal of Cancer. 132(12). 2858–2866. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaosheng Xu Breakdown of academic impact, for papers by Yilin Wu Breakdown of academic impact, for papers by Hirofumi Ando Breakdown of academic impact, for papers by Brian K. Stevens Breakdown of academic impact, for papers by Takahiro Tabata Breakdown of academic impact, for papers by Keng Ye Breakdown of academic impact, for papers by Beatriz Palacios Breakdown of academic impact, for papers by Dongli Tian Breakdown of academic impact, for papers by Chihiro Horimai
Rankless by CCL
2026